• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer.

作者信息

Hague C, Foran B, Hall E, Guild S, Joseph O, Moule R, Nutting C, Parsons S, Prestwich R, Slevin N, West C, Thomson D

机构信息

The Christie NHS Foundation Trust, Manchester, UK.

Weston Park Hospital, Sheffield, UK.

出版信息

Clin Oncol (R Coll Radiol). 2018 May;30(5):274-276. doi: 10.1016/j.clon.2018.01.018. Epub 2018 Feb 17.

DOI:10.1016/j.clon.2018.01.018
PMID:29459100
Abstract
摘要

相似文献

1
Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer.患者参与一项比较调强质子治疗与调强放射治疗口咽癌的III期试验的设计。
Clin Oncol (R Coll Radiol). 2018 May;30(5):274-276. doi: 10.1016/j.clon.2018.01.018. Epub 2018 Feb 17.
2
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.比较调强质子治疗与调强光子治疗口咽癌：从临床试验理念到实施的历程。
Semin Radiat Oncol. 2018 Apr;28(2):108-113. doi: 10.1016/j.semradonc.2017.12.002.
3
TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer.TORPEdO——一项比较调强质子束治疗与调强放射治疗以降低口咽癌多种毒性的III期试验。
Clin Oncol (R Coll Radiol). 2020 Feb;32(2):84-88. doi: 10.1016/j.clon.2019.09.052. Epub 2019 Oct 8.
4
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.TORPEdO：一项关于调强质子束治疗与调强放射治疗对比以降低口咽癌多种毒性的III期试验。
Clin Transl Radiat Oncol. 2022 Nov 21;38:147-154. doi: 10.1016/j.ctro.2022.11.010. eCollection 2023 Jan.
5
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.质子治疗头颈部 HPV 相关口咽癌：一种减毒策略。
Curr Treat Options Oncol. 2021 Jun 4;22(6):54. doi: 10.1007/s11864-021-00847-y.
6
High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.高强度调强质子治疗与标准剂量调强放疗治疗食管鳞癌（HI-SIRI）：一项随机对照临床试验研究方案。
Trials. 2022 Oct 22;23(1):897. doi: 10.1186/s13063-022-06822-8.
7
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.调强质子治疗与调强光子放射治疗用于口咽癌：患者报告结局的首次比较结果
Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1107-14. doi: 10.1016/j.ijrobp.2016.02.044. Epub 2016 Feb 18.
8
Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.与调强放射治疗相比，调强质子治疗对头颈部癌的剂量学优势：病例匹配对照分析。
Med Dosim. 2016 Autumn;41(3):189-94. doi: 10.1016/j.meddos.2016.01.002. Epub 2016 May 4.
9
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.接受调强质子治疗与调强放射治疗的非转移性口咽癌患者的毒性特征和生存结果。
JAMA Netw Open. 2022 Nov 1;5(11):e2241538. doi: 10.1001/jamanetworkopen.2022.41538.
10
Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study.采用调强放疗（IMRT）或质子放疗-GRIPS 试验（Glioblastoma Radiotherapy via IMRT or Proton BeamS）治疗胶质母细胞瘤的放射治疗：一项多中心、前瞻性、开放标签、随机、双臂、III 期研究的研究方案。
Radiat Oncol. 2021 Dec 20;16(1):240. doi: 10.1186/s13014-021-01962-8.

引用本文的文献

1
Impact of patient information format on the experience of cancer patients treated with radiotherapy.患者信息格式对接受放射治疗的癌症患者体验的影响。
Tech Innov Patient Support Radiat Oncol. 2024 May 9;30:100252. doi: 10.1016/j.tipsro.2024.100252. eCollection 2024 Jun.
2
Engineering the mode of morphogenetic signal presentation to promote branching from salivary gland spheroids in 3D hydrogels.通过设计形态发生信号呈现方式来促进唾液腺球体在 3D 水凝胶中的分支。
Acta Biomater. 2020 Mar 15;105:121-130. doi: 10.1016/j.actbio.2020.01.027. Epub 2020 Jan 24.
3
Proton beam therapy: perspectives on the National Health Service England clinical service and research programme.
质子束疗法：对英国国民保健服务临床服务和研究计划的看法。
Br J Radiol. 2020 Mar;93(1107):20190873. doi: 10.1259/bjr.20190873. Epub 2020 Jan 14.
4
Innovating public engagement and patient involvement through strategic collaboration and practice.通过战略合作与实践创新公众参与和患者参与。
Res Involv Engagem. 2019 Oct 21;5:30. doi: 10.1186/s40900-019-0160-4. eCollection 2019.
5
Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy.评估质子束治疗益处的临床研究中所用方法的系统评价。
Clin Transl Radiat Oncol. 2019 Jul 12;19:17-26. doi: 10.1016/j.ctro.2019.07.002. eCollection 2019 Nov.
6
Codelivery of DOX and siRNA by folate-biotin-quaternized starch nanoparticles for promoting synergistic suppression of human lung cancer cells.叶酸-生物素-季铵化淀粉纳米粒共载 DOX 和 siRNA 促进协同抑制人肺癌细胞。
Drug Deliv. 2019 Dec;26(1):499-508. doi: 10.1080/10717544.2019.1606363.